Trial Profile
Evaluation of Clinical Signs and Symptoms of Chronic Heart Failure in Patients Treated With Candesartan Cilexetil in Croatia.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Jan 2011
Price :
$35
*
At a glance
- Drugs Candesartan cilexetil (Primary)
- Indications Chronic heart failure
- Focus Therapeutic Use
- 06 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Oct 2009 New trial record